Change in gene expression of mouse embryonic stem cells derived from parthenogenetic activation

Author: Gong Seung Pyo   Kim Heebal   Lee Eun Ju   Lee Seung Tae   Moon Sunjin   Lee Ho-Joon   Lim Jeong Mook  

Publisher: Oxford University Press

ISSN: 1460-2350

Source: Human Reproduction, Vol.24, Iss.4, 2009-04, pp. : 805-814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

BACKGROUND We previously established parthenogenetic mouse embryonic stem cells (ESCs) and this study was subsequently conducted for elucidating the influence of oocyte parthenogenesis on gene expression profile of ESCs. METHODS Gene expression of parthenogenetic ESC (pESC)-1 or pESC-2 was separately compared with that of two normally fertilized ESC (nfESC) lines (B6D2F1 and R1 strains), and quantification of mRNA expression was conducted for validating microarray data. RESULTS In two sets of comparison, reaction of 11 347 and 15 454 gene probes were altered by parthenogenesis, while strain difference changed the expression of 15 750 and 14 944 probes. Level of correlation coefficient was higher in the comparisons between normal fertilization and parthenogenesis (0.9740.985) than in the comparisons between strains of nfESCs (0.970.971). Overall, the expression of 32763329 genes was changed after parthenogenesis, and 88% (96/109) of major functional genes differentially (P < 0.01)="" expressed="" in="" one="" comparison="" set="" showed="" the="" same="" change="" in="" the="" other.="" when="" we="" monitored="" imprinted="" genes,="" expression="" of="" nine="" paternal="" and="" eight="" maternal="" genes="" were="" altered="" after="" parthenogenesis="" and="" 88%="" (14/16)="" of="" these="" was="" confirmed="" by="" mrna=""> CONCLUSIONS The change in gene expression after parthenogenesis was similar to, or less than, the change induced by a strain difference under a certain genetic background. These results may suggest the clinical feasibility of parthenogenesis-derived, pluripotent cells.

Related content